Clinical Trial Update: Intravenous Immunoglobulins for Post-Polio Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating intravenous immunoglobulins for post-polio syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-polio Syndrome

Drugs mentioned

• IntraVenous ImmunoGlobulins (intravenous immunoglobulin)

Snippet

Sponsor: Azienda Ospedaliera Universitaria Integrata Verona | Conditions: Post-polio Syndrome | Phase 3 | Status: COMPLETED